Diagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC)
0:00 - Introduction by Miguel Tam, PhD, Director of Strategic Marketing, BioLegend
"BioLegend Flow Cytometry and Multiplex Product Overview"
In this presentation, Dr. Tam will outline BioLegend's Flow Cytometry reagents, types of fluorophores, and the BioLegend portfolio and workflow for multiplex soluble molecule detection. He will also discuss BioLegend's LEGENDplexTM product and solutions.
08:20 - Dr. Bruce Patterson, MD, CEO & Founder of InCellDX
"Diagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC)
In this presentation, Dr. Patterson discusses how some people with COVID-19 experience lingering symptoms for weeks or months, known as post-acute sequelae SARS-CoV-2 infection (PASC). He will share the story of 3,000 “long haulers” in his group’s Chronic COVID Treatment Center™ program, a collaboration between research facilities, clinicians, and medical laboratories. He will discuss novel tools developed with BioLegend to diagnose, treat, and discover the possible underlying immunologic mechanisms in PASC and the debilitating effects on those suffering from these sequelae even a year later.
Explore our SARS-CoV-2 Research Tools https://www.biolegend.com/en-us/sars-cov-research
Видео Diagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC) канала BioLegend
"BioLegend Flow Cytometry and Multiplex Product Overview"
In this presentation, Dr. Tam will outline BioLegend's Flow Cytometry reagents, types of fluorophores, and the BioLegend portfolio and workflow for multiplex soluble molecule detection. He will also discuss BioLegend's LEGENDplexTM product and solutions.
08:20 - Dr. Bruce Patterson, MD, CEO & Founder of InCellDX
"Diagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC)
In this presentation, Dr. Patterson discusses how some people with COVID-19 experience lingering symptoms for weeks or months, known as post-acute sequelae SARS-CoV-2 infection (PASC). He will share the story of 3,000 “long haulers” in his group’s Chronic COVID Treatment Center™ program, a collaboration between research facilities, clinicians, and medical laboratories. He will discuss novel tools developed with BioLegend to diagnose, treat, and discover the possible underlying immunologic mechanisms in PASC and the debilitating effects on those suffering from these sequelae even a year later.
Explore our SARS-CoV-2 Research Tools https://www.biolegend.com/en-us/sars-cov-research
Видео Diagnosis, Treatment and Immunopathogenesis of Chronic COVID-19 (PASC) канала BioLegend
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Cancer Neoantigens as Targets for Natural and Therapeutic Anti-Tumor ResponsesTech Insights: Spike-In Antibodies to TotalSeq™ CocktailsWebinar: New Checkpoint Molecules That Regulate Anti-Tumor ImmunityTech Insights: Fixation in Flow CytometryTech Insights: Flow Cytometry BuffersCell Signaling in Cancer: New Targets, New HopeModulating In Vivo T-cell Activation3-D IHC: Mouse small intestine - CD326 (Ep-CAM), Tubulin Beta 3 (TUBB3), Helix NP™ GreenLEGENDplex™ Cloud-Based Software TutorialThe Ken Lau Show Episode 10 - AutofluorescenceTech Insights: TotalSeq™ Data AnalysisBioLegend MojoSort™ Protocol VideoInflammatory Chemokines in COVID-19MAS Demo I: Filtering and DemultiplexingChromogenic Tissue Staining using DAB Detection SystemDeep Characterization of Viral and Self-Antigen Peptide-Induced Cellular Immune ResponsesWebinar: Unpacking the Genetic Contribution of Glia to Parkinson’s DiseaseWebinar: A Single-Cell Multiomics Workflow: Impact of Human Disease Variants on Relevant Cell StatesFighting Cancer from Multiple Angles: Exploring RANK-RANKL, and PD-L1 in mouse melanoma models.BioLegend Recombinant ProteinsFrom Research to Cure, BioLegend Documentary